| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways. | Sorin, S Zhou, Y Thithuan, K Khawkhiaw, K Zeng, F Ruangpratyakul, T Chomphoo, S Seubwai, W Wongkham, S Saengboonmee, C |
2023 | ||||
| 2. | Hyperglycemia Alters -GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen. | Chomphoo, S Kunprom, W Thithuan, K Sorin, S Khawkhiaw, K Kamkaew, A Phoomak, C Chiu, CF Saengboonmee, C |
2023 | ||||
| 3. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 | ||||
| 4. | Interleukin-1β: Friend or foe for gastrointestinal cancers. | Khawkhiaw, K Panaampon, J Imemkamon, T Saengboonmee, C |
2024 | ||||
| 5. | Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma. | Khawkhiaw, K Chomphoo, S Kunprom, W Thithuan, K Sorin, S Yueangchantuek, P Chiu, CF Umezawa, K Panaampon, J Okada, S Wongkham, S Saengboonmee, C |
2024 | ||||
| 6. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 | ||||
| 7. | Activation of the γ-Aminobutyric Acid Receptor Type B Suppresses the Proliferation of Lung Adenocarcinoma Cells. | Zhou, Y Khawkhiaw, K Thithuan, K Saengboonmee, C |
2025 | Count | 1 | 6 | 0 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 |
In Vivo 2 (37), pp. 685-695 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways. | Sorin, S Zhou, Y Thithuan, K Khawkhiaw, K Zeng, F Ruangpratyakul, T Chomphoo, S Seubwai, W Wongkham, S Saengboonmee, C |
2023 |
The Journal of nutritional biochemistry (), pp. 109399 |
|
| 2. | Hyperglycemia Alters -GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen. | Chomphoo, S Kunprom, W Thithuan, K Sorin, S Khawkhiaw, K Kamkaew, A Phoomak, C Chiu, CF Saengboonmee, C |
2023 |
In vivo (Athens, Greece) 2 (37), pp. 685-695 |
|
| 3. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 |
Scientific reports 1 (14), pp. 13726 |
|
| 4. | Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma. | Khawkhiaw, K Chomphoo, S Kunprom, W Thithuan, K Sorin, S Yueangchantuek, P Chiu, CF Umezawa, K Panaampon, J Okada, S Wongkham, S Saengboonmee, C |
2024 |
Translational gastroenterology and hepatology (9), pp. 36 |
|
| 5. | Interleukin-1β: Friend or foe for gastrointestinal cancers. | Khawkhiaw, K Panaampon, J Imemkamon, T Saengboonmee, C |
2024 |
World journal of gastrointestinal oncology 5 (16), pp. 1676-1682 |
|
| 6. | Activation of the γ-Aminobutyric Acid Receptor Type B Suppresses the Proliferation of Lung Adenocarcinoma Cells. | Zhou, Y Khawkhiaw, K Thithuan, K Saengboonmee, C |
2025 |
Anticancer research 4 (45), pp. 1513-1523 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|